Single Use Biliary Drainage Stent V PBD-1031-0711Recalls & reported problems
Olympus Medical Systems Corp. · Class 2 · Implant
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 04953170346439), received between Oct 8, 2024 and Oct 8, 2024 — classified as 2 injuries.
The most frequently reported specific device problem is “Migration” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
- Migration1
Patient problems
- Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available1
- Hemorrhage/Blood Loss/Bleeding1
- Obstruction/Occlusion1
- Peritonitis1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
InjuryOct 8, 2024Migration; Migration
OLYMPUS REVIEWED THE FOLLOWING LITERATURE TITLED "SAFE PERFORMANCE OF TRACK DILATION AND BILE ASPIRATION WITH ERCP CATHETER IN EUS-GUIDED HEPATICOGASTROSTOMY WITH PLASTIC STENTS: A RETROSPECTIVE MULTICENTER STUDY." LITERATURE SUMMARY ABSTRACT OBJECTIVES: ENDOSCOPIC-ULTRASOUND-GUIDED HEPATICOGASTROSTOMY (EUS-HGS) WITH PLASTIC STENT PLACEMENT IS ASSOCIATED WITH A HIGH INCIDENCE OF ADVERSE EVENTS THAT MAY BE REDUCED USING AN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) CONTRAST CATHETER IN THE TRACK DILATION STEP. IN THIS STUDY, WE EVALUATED THE USEFULNESS OF TRACK DILATION AND BILE ASPIRATION PERFORMED WITH AN ERCP CONTRAST CATHETER IN EUS-HGS WITH PLASTIC STENT PLACEMENT. METHODS: IN A MULTICENTER SETTING, 22 EUS-HGS CASES DILATED WITH AN ERCP CONTRAST CATHETER WERE ANALYZED RETROSPECTIVELY AND COMPARED BETWEEN A BILE ASPIRATION GROUP AND NO BILE ASPIRATION GROUP. RBO WAS DEFINED AS THE RECURRENCE OF OBSTRUCTIVE JAUNDICE AND/OR CHOLANGITIS DUE TO STENT OCCLUSION OR MIGRATION. ADVERSE EVENTS OTHER THAN RBO WERE CATEGORIZED AS POST-PROCEDURE COMPLICATIONS, WHICH INCLUDED BILE LEAKAGE, PERITONITIS, BLEEDING, PERFORATION, PANCREATITIS, CHOLECYSTITIS, ASPIRATION PNEUMONIA, LIVER
Patient problems: Obstruction/Occlusion
MAUDE report 20397085 ↗InjuryOct 8, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
OLYMPUS REVIEWED THE FOLLOWING LITERATURE TITLED "SAFE PERFORMANCE OF TRACK DILATION AND BILE ASPIRATION WITH ERCP CATHETER IN EUS-GUIDED HEPATICOGASTROSTOMY WITH PLASTIC STENTS: A RETROSPECTIVE MULTICENTER STUDY." LITERATURE SUMMARY: ABSTRACT OBJECTIVES: ENDOSCOPIC-ULTRASOUND-GUIDED HEPATICOGASTROSTOMY (EUS-HGS) WITH PLASTIC STENT PLACEMENT IS ASSOCIATED WITH A HIGH INCIDENCE OF ADVERSE EVENTS THAT MAY BE REDUCED USING AN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) CONTRAST CATHETER IN THE TRACK DILATION STEP. IN THIS STUDY, WE EVALUATED THE USEFULNESS OF TRACK DILATION AND BILE ASPIRATION PERFORMED WITH AN ERCP CONTRAST CATHETER IN EUS-HGS WITH PLASTIC STENT PLACEMENT. METHODS: IN A MULTICENTER SETTING, 22 EUS-HGS CASES DILATED WITH AN ERCP CONTRAST CATHETER WERE ANALYZED RETROSPECTIVELY AND COMPARED BETWEEN A BILE ASPIRATION GROUP AND NO BILE ASPIRATION GROUP. RBO WAS DEFINED AS THE RECURRENCE OF OBSTRUCTIVE JAUNDICE AND/OR CHOLANGITIS DUE TO STENT OCCLUSION OR MIGRATION. ADVERSE EVENTS OTHER THAN RBO WERE CATEGORIZED AS POST-PROCEDURE COMPLICATIONS, WHICH INCLUDED BILE LEAKAGE, PERITONITIS, BLEEDING, PERFORATION, PANCREATITIS, CHOLECYSTITIS, ASPIRATION PNEUMONIA, LIVE
Patient problems: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available; Hemorrhage/Blood Loss/Bleeding; Peritonitis
MAUDE report 20397083 ↗
Other CATHETER, BILIARY, DIAGNOSTIC devices
- Hurricane™ RX M00545900Boston Scientific Corporation · CATHETER, BILIARY, DIAGNOSTIC2 recalls1 death705 reports
- MUSTANG™ H74939171060470Boston Scientific Corporation · CATHETER, BILIARY, DIAGNOSTIC384 reports
- CRE™ PRO M00558710Boston Scientific Corporation · CATHETER, BILIARY, DIAGNOSTIC1 recall284 reports
- Hurricane™ RX M00545920Boston Scientific Corporation · CATHETER, BILIARY, DIAGNOSTIC2 recalls211 reports
- MUSTANG™ H74939171070470Boston Scientific Corporation · CATHETER, BILIARY, DIAGNOSTIC265 reports
- MUSTANG™ H74939171050470Boston Scientific Corporation · CATHETER, BILIARY, DIAGNOSTIC212 reports
- Hurricane™ RX M00545940Boston Scientific Corporation · CATHETER, BILIARY, DIAGNOSTIC2 recalls109 reports
- MUSTANG™ H74939171100470Boston Scientific Corporation · CATHETER, BILIARY, DIAGNOSTIC203 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page